Vitamin D and the mammary gland: a review on its role in normal development and breast cancer Full Text
Breast Cancer Research,  Review Article

Lopes N. et al .– The present review highlights research data concerning the function of Vitamin D hormone in the mammary gland, with a special focus on breast carcinogenesis. Hence, and although the available data are controversial, the authors consider not only updated information on the epidemiology of vitamin D in breast cancer and its potential value as a therapeutic agent or prophylactic (with an emphasis on molecular mechanisms and effectors of vitamin D action), but include data on its role in other stages of breast cancer progression as well. Accordingly, they also review data on the influence of vitamin D in the development of normal breast and the expression of vitamin D–related proteins (VDR, CYP27B1 and CYP24A21) in benign mammary lesions and ductal carcinomas in situ.

  • Breast cancer is a heterogeneous disease associated with diverse biological behaviours and clinical outcome.
  • Although some molecular subgroups of breast cancer have a targeted therapy, the most aggressive tumours still lack a molecular target.
  • Despite vitamin D being classically associated with the physiological role of calcium regulation and phosphate transport in bone metabolism, several studies have demonstrated a wide range of functions for this hormone, which are particularly important in the field of cancer.
  • The mechanisms underlying the protective actions of vitamin D in cancer development are only sparsely understood, but evidence shows that vitamin D participates in cell growth regulation, apoptosis and cell differentiation.
  • In addition, it has been implicated in the suppression of cancer cell invasion, angiogenesis and metastasis.
  • Most of vitamin D biological actions are mediated by the vitamin D receptor and the synthesis and catabolism of this hormone are regulated by the enzymes CYP27B1 and CYP24A1.
  • The data described provide evidence for an essential role of vitamin D in normal development of the mammary gland and breast cancer.
  • Epidemiological studies are conflicting and their results not consistent, with the current view indicating no protective role for vitamin D in breast cancer development.
  • Still, the different functions and effects of vitamin D on cancer cell biology, such as the cell cycle, apoptosis, invasion and metastasis, as well as angiogenesis, virtually bring together the entire spectrum of tumour development under its purview.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Obstetrics & Gynecology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Obstetrics & Gynecology Articles

1 Antiphospholipid antibody syndrome and reproduction Current Opinion in Obstetrics and Gynecology, July 14, 2014    Clinical Article

2 Systematic validation of hypothesis-driven candidate genes for cervical cancer in a genome-wide association study Carcinogenesis, July 18, 2014    Clinical Article

3 Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women Cancer Epidemiology, Biomarkers & Prevention, June 25, 2014    Clinical Article

4 In utero resolution of microcystic congenital cystic adenomatoid malformation after prenatal betamethasone therapy: A report of three cases and a literature review Journal of Clinical Ultrasound, July 23, 2014

5 Increased risk of gonadal malignancy and prophylactic gonadectomy: A study of 102 phenotypic female patients with Y chromosome or Y-derived sequences Human Reproduction, June 25, 2014    Clinical Article

6 Is superfertility associated with recurrent pregnancy loss? American Journal of Reproductive Immunology, June 26, 2014    Clinical Article

7 Modifying the osteoblastic niche with zoledronic acid - potential implications for breast cancer bone metastasis Bone, June 27, 2014    Evidence Based Medicine

8 Understanding the complexity of the immune system during pregnancy American Journal of Reproductive Immunology, July 11, 2014    Review Article

9 CCNB1 is a prognostic biomarker for ER+ breast cancer Medical Hypotheses, July 16, 2014    Review Article

10 Cyclooxygenase-2 inhibitor, celecoxib, inhibits leiomyoma cell proliferation through the nuclear factor κb pathway Reproductive Sciences, July 29, 2014    Clinical Article

11 Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosis Full Text The Oncologist, June 25, 2014    Free full text    Clinical Article

12 Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors Full Text Clinical Sarcoma Research, July 17, 2014    Free full text    Review Article

13 Mechanical signaling in reproductive tissues: Mechanisms and importance Reproductive Sciences, July 29, 2014    Clinical Article

14 Tp53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance Clinical Cancer Research, June 23, 2014    Clinical Article

15 The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency Human Reproduction, June 26, 2014    Clinical Article

16 Role of protein kinase A in regulating steroid sulfate uptake for estrogen production in human placental choriocarcinoma cells Placenta, July 7, 2014    Clinical Article

17 Improved overall survival after contralateral risk-reducing mastectomy in Brca1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis International Journal of Cancer, June 23, 2014    Clinical Article

18 B cells: the old new players in reproductive immunology Frontiers in Immunology, July 14, 2014    Clinical Article

19 Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53 Cancer, July 22, 2014    Clinical Article

20 Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer European Journal of Cancer, July 23, 2014    Clinical Article

Indexed Journals in Obstetrics & Gynecology: Obstetrics and Gynecology, American Journal of Obstetrics and Gynecologymore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close